Skip to main content

Table 2 Schedule of enrollment, interventions, and assessments

From: Effects of β-hydroxy-β-methylbutyrate (HMB) supplementation in addition to multicomponent exercise in adults older than 70 years living in nursing homes, a cluster randomized placebo-controlled trial: the HEAL study protocol

TIMEPOINT

Enrollment

-t1

Allocation

0

Baseline

t1

Intervention

Follow-up

12th week post baseline

t2

Close-out

25th week post baseline

t3

ENROLLMENT

 Eligibility screen

     

 Informed consent

     

 Randomized Allocation

 

    

INTERVENTION

   

  

 Ex-HMB

   

  

 NoEx-HMB

   

  

 Ex-Plac

   

  

 Control

   

  

ASSESSMENTS

Functional capacity (primary outcome)

  SPPB: Gait speed, balance, and 5-sit-to-stand

 

 

Muscle strength and power

  Grip strength

  

 

  1RM seated leg press

  

 

  1RM vertical bench press

  

 

  Sit-to-stand muscle power

  

 

Frailty and fall risk

  Frailty phenotype

  

 

  Falls history

 

 

  Fall risk assessment

 

 

Body composition

  

  

Blood pressure and resting heart rate

  

 

Haematology

  

 

Biochemical analyses

  

 

Nutritional status

  

 

Sarcopenia

  

 

Disability and comorbidity

  Barthel index

  

 

  Lawton index

  

 

  Comorbidity

  

 

Cognitive function

 

 

Depression

  

 

  1. Ex: 12-week of VIVIFRAIL multicomponent exercise program. HMB: dietary supplementation of HMB. Plac Placebo. SPPB Short Physical Performance Battery; 1RM one-repetition maximum